“…Cerebrovascular disease is the fourth leading cause of death, which occupies 6.0%, and its prevention is critical in the field of dialysis therapy in Japan [1] . Furthermore, in patients undergoing hemodialysis (HD), diabetes mellitus and hypertension resulting in chronic kidney disease (CKD) and CKD-mineral and bone metabolism disorders are frequently associated with accelerated atherosclerosis and could lead to the high prevalence of carotid artery stenosis [2] , [3] , [4] . Carotid artery stenting (CAS) is considered feasible and effective for the prevention of cerebrovascular disease because of the recent favorable findings of carotid revascularization, including CAS, for the dialysis patients with carotid artery stenosis [ 5 , 6 ].…”